Accelera Medtech Canada Enters into the Post-Concussion Management Market with the Acquisition of Iris Technologies
The Iris Monitor, finds a new home with Ontario-based Accelera Medtech Canada
"Our acquisition of Iris Technologies is in line with our vision to bring innovative medical technologies to the Canadian and, through partnerships, global markets. This investment represents an important strategic opportunity to build a portfolio of medical and consumer healthcare offerings that we believe will improve the health and well-being of patients living with traumatic brain injuries such as concussions,"
Iris Technologies is a Canadian assistive technology start-up founded in 2015 by two Queen's University graduates, Colin Harding and Conor Ross, seeking to offer concussion patients a faster road back to work and the classroom. "Colin and I are incredibly excited about the opportunity this affords Iris. Our biggest priority has always been to get the Iris Monitor in the hands of those who need it most and Accelera Medtech allows the company to do this in a substantial way. We could not have got to this point without the help of our families, investors, The Canadian Concussion Centre, Queens Innovation Connector, and The Ryerson Biomedical Zone."
With one in five Canadians affected by a sport-related concussion injury1 and 1.5 million currently living with a brain injury2, there is a significant financial burden borne by patients, businesses and insurers due to the inability of many concussion patients to return to work or school.
More information about the Iris Monitor can be found on the company website:
To learn more about Accelera Medtech Canada, visit https://www.acceleramedtech.com.
CEO, Accelera Medtech Canada Inc.